靶点说明
MART1 (27-35) AAGIGILTV HLA-A*02:01
HLA类型
抗原和HLA的亲和力
NetMHCpan 4.1 计算AAGIGILTV与HLA-A*02:01亲和力为 3874.86 nM。
产品类型和应用
| 产品类型 | 规格 | 价格 |
| 流式检测与分选 | MART1 (27-35) HLA-A*02:01 PE / APC / Alexa Fluor 488 | 7200元/50ug, 11800元/100ug |
| 磁珠分选 | MART1 (27-35) HLA-A*02:01 HLA-A*02:01磁珠 | 8200元/50ug, 12800元/100ug |
| 生物素化复合物 | MART1 (27-35) HLA-A*02:01 HLA-A*02:01-biotin | 6800元/50ug, 11400元/100ug |
实测结果
肽刺激PBMC后检测抗原特异性CD8+T细胞
AAGIGILTV多肽刺激HLA-A*02:01限制性PBMC后，使用MART1 (27-35) HLA-A*02:01 PE 四聚体和抗CD8-FITC抗体检测。下图左图为抗原肽AAGIGILTV刺激组，右图为未加抗原肽刺激组。
靶点结合的TCR序列
请查看IEDB数据库
相关文章
| Reference – PMID | Reference – Journal | Reference – Date | Reference – Title |
|---|---|---|---|
| 7706734 | J Immunol | 1995 | Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. |
| 7868898 | J Immunol | 1995 | Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. |
| 8938271 | Semin Cancer Biol | 1995 | Epitope selection and development of peptide based vaccines to treat cancer. |
| 9862732 | J Immunol | 1998 | HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. |
| 10540322 | Eur J Immunol | 1999 | H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. |
| 12972191 | J Immunol Methods | 2003 | In situ detection of antigen-specific tumor-infiltrating lymphocytes using newly designed tetramers. |
| 15723046 | Nat Biotechnol | 2005 | Directed evolution of human T-cell receptors with picomolar affinities by phage display. |
| 18424733 | J Immunol | 2008 | Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. |
| 16197958 | J Mol Biol | 2005 | Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants. |
| 17719062 | J Mol Biol | 2007 | Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. |
| 16455990 | J Immunol | 2006 | Ex vivo characterization of allo-MHC-restricted T cells specific for a single MHC-peptide complex. |
| 10958352 | Tissue Antigens | 2000 | Identification of tumor antigen-specific cytotoxic T lymphocytes cross-recognizing allogeneic major histocompatibility class I molecules. |
| 21093097 | Immunobiology | 2011 | IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity. |
| 17056587 | J Immunol | 2006 | Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. |
| 18942640 | Prostate | 2009 | The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer. |
| 22952231 | J Biol Chem | 2012 | T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. |
| 24550723 | PLoS Comput Biol | 2014 | Computational design of the affinity and specificity of a therapeutic T cell receptor. |
| 21795600 | J Immunol | 2011 | TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. |
| 25198529 | J Immunother | 2014 | TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation. |
| 11886495 | J Invest Dermatol | 2001 | Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. |
| 25505266 | J Biol Chem | 2015 | Naturally processed non-canonical HLA-A*02:01 presented peptides. |
| 25589627 | Clin Cancer Res | 2015 | Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte-Derived HLA-Ligandome Using a Reverse Immunology Approach. |
| 28489076 | Nat Commun | 2017 | HLA-DP<sup>84Gly</sup> constitutively presents endogenous peptides generated by the class I antigen processing pathway. |
| 10916751 | J Immunother | 2000 | Quantitation of T-cell receptor frequencies by competitive polymerase chain reaction: dynamics of T-cell clonotype frequencies in an expanding tumor-infiltrating lymphocyte culture. |
| 21937447 | J Biol Chem | 2011 | Loss of T cell antigen recognition arising from changes in peptide and major histocompatibility complex protein flexibility: implications for vaccine design. |
| 23954306 | J Mol Biol | 2013 | Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes. |
| 30425106 | Cancer Immunol Res | 2019 | High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity Predictions. |
| 30700903 | Nat Methods | 2019 | T cell antigen discovery via trogocytosis. |
| 30617019 | Mol Ther | 2019 | Improving T Cell Receptor On-Target Specificity via Structure-Guided Design. |
| 31091334 | Eur J Immunol | 2019 | TCR-induced alteration of primary MHC peptide anchor residue. |
| 32184297 | Cancer Immunol Res | 2020 | Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform. |
| 32314731 | Elife | 2020 | Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma. |
| 11684128 | J Immunol Methods | 2001 | Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells. |
| 32241816 | Clin Cancer Res | 2020 | Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells. |
| 34290406 | Nature | 2021 | Phenotype, specificity and avidity of antitumour CD8<sup>+</sup> T cells in melanoma. |
| 36608422 | Mol Immunol | 2023 | ERAP2 supports TCR recognition of three immunotherapy targeted tumor epitopes. |
| 35874702 | Front Immunol | 2022 | Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade. |
| 35508657 | Nature | 2022 | Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanoma. |
| 37490916 | Cell | 2023 | Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy. |
| 26079729 | J Immunol Methods | 2015 | Unpredicted phenotypes of two mutants of the TcR DMF5. |
| 23391568 | Hum Immunol | 2013 | Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly. |
